查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618595

医疗事务外包市场：按服务、业务模式和最终用户划分 - 全球预测 2025-2030

Medical Affairs Outsourcing Market by Services, Operational Model, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医疗事务外包市场规模为97.8亿美元，预计2024年将达到111.6亿美元，复合年增长率为14.59%，预计到2030年将达到253.9亿美元。

医疗事务外包涉及与第三方供应商签订合同，管理製药、生物技术和医疗设备公司医疗事务部门内的各种职能。外包的关键服务包括医学写作、监管提交、医疗资讯和策略咨询，以确保遵守不断变化的法规。外包的需求源自于优化业务效率、专注于核心竞争力、降低成本和解决资源稀缺挑战的需要，尤其是中小型企业。其应用范围从临床试验资料管理到行销、药物安全和医学教育，最终支援产品发布和生命週期管理。创新正在推动成长，特别是在製药和生物技术领域，需要专业知识的复杂治疗领域不断增加。

主要市场统计
基准年[2023] 97.8亿美元
预计年份 [2024] 111.6亿美元
预测年份 [2030] 253.9亿美元
复合年增长率（%） 14.59%

影响成长的关键因素包括研发费用增加、对特殊药物的关注增加以及对合规和监管管理的需求增加。现代商业机会由人工智慧和机器学习等技术进步提供动力，这些技术进步可以改善资料管理、分析和决策流程。企业可以透过投资技术主导的解决方案并与创新的外包服务提供者建立伙伴关係来利用这些优势。然而，资料隐私问题、品管问题以及维持第三方和内部团队之间有凝聚力的沟通管道等挑战构成了重大障碍。监管环境也在不断发展，增加了维持合规性的复杂性。

创新机会在于使用需要严格医疗事务投入的数位健康工具和个人化医疗方法。专注于整合人工智慧进行即时资料分析和预测洞察的研究领域将提供长期价值。由于市场的特点是技术快速采用和激烈竞争，公司应致力于策略性投资于敏捷且可扩展的解决方案。专注于合规性、利用策略联盟并增强服务产品以有效满足不断变化的客户需求是成功的关键。

市场动态：揭示快速发展的医疗事务外包市场的关键市场洞察

医疗事务外包市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 扩大药物管道并增加临床资料的复杂性
    • 医学出版品和教育内容的增加
    • 对实证医学和价值医疗保健的需求不断增长
  • 市场限制因素
    • 与委託职能的沟通和品质相关的限制
  • 市场机会
    • 将人工智慧和机器学习技术融入医疗事务外包
    • 製药公司与外包公司的策略合作
  • 市场挑战
    • 对机密性和资料安全风险的担忧

波特五力：驾驭医疗事务外包市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医疗事务外包市场的外部影响

外部宏观环境因素在塑造医疗事务外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解医疗事务外包市场的竞争状况

医疗事务外包市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医疗事务外包市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估医疗事务外包市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製医疗事务外包市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对医疗事务外包市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大药物管道并增加临床资料的复杂性
      • 医学出版品和教育内容的增加
      • 对实证医学和价值医疗保健的需求不断增长
    • 抑制因素
      • 与外包职能的沟通和品质相关的限制
    • 机会
      • 将人工智慧和机器学习技术融入医疗事务外包
      • 製药公司与外包公司的策略合作
    • 任务
      • 对机密性和资料安全风险的担忧
  • 市场区隔分析
    • 服务：更多采用医疗业务外包，为复杂的监管路径提供策略指导
    • 营运模式：采用功能性服务模式来获得医学写作和资料分析关键领域的有针对性的专业知识
    • 最终用户：透过最终用户的多样化应用程式简化营运成本
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 医疗事务外包市场：依服务分类

  • 医疗通讯
  • 医疗资讯服务
  • 医疗监测
  • 医药学术专员
  • 医学写作和出版

第七章依营运模式分類的医疗事务外包市场

  • 全程服务外包
  • 功能外包
  • 部分/任务式的外包

第八章 医疗事务外包市场：依最终使用者分类

  • 生物技术和製药公司
  • 合约调查机构
  • 医院
  • 医疗设备公司
  • 疗养院

第九章 美洲医疗事务外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太医疗事务外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲医疗事务外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 全球医疗技术 CRO NAMSA 宣布与Terumo Corporation Aorta 建立策略外包伙伴关係
    • Millstone 医疗外包完成无尘室设施扩建
    • 工业和百时美施贵宝与 PRiME-R 签署委託，在日本利用网路肿瘤学对Opdivo进行胃癌患者的临床研究
  • 战略分析和建议

公司名单

  • Accenture PLC
  • Ashfield Healthcare Communications by Inizio
  • Biomapas Group
  • Charles River Laboratories International, Inc.
  • Comprehend Systems, Inc. by Saama Technologies, Inc.
  • Excelya
  • Freyr Solutions
  • Genpact
  • Groupe ProductLife SA
  • ICON PLC
  • Indegene, Inc.
  • Insuvia
  • IQVIA Holdings, Inc.
  • JSS Medical Research Inc
  • Medpace Holdings, Inc.
  • MMS Holdings Inc.
  • PAREXEL International Corporation
  • Pharmalex by BlueReg
  • PPD, Inc. by Thermo Fischer Scientific Inc.
  • ProPharma Group
  • SGS SA
  • Syneos Health, Inc.
  • The Medical Affairs Company
  • Wuxi Clinical Development, Inc.
  • Zeincro Group
Product Code: MRR-433C4187C541

The Medical Affairs Outsourcing Market was valued at USD 9.78 billion in 2023, expected to reach USD 11.16 billion in 2024, and is projected to grow at a CAGR of 14.59%, to USD 25.39 billion by 2030.

Medical Affairs Outsourcing involves contracting third-party vendors to manage various functions within the medical affairs segments of pharmaceutical, biotechnology, and medical device companies. Core services often outsourced include medical writing, regulatory submissions, medical information, and strategic consultancy, ensuring compliance with ever-changing regulations. The necessity for outsourcing arises from the need to optimize operational efficiencies, focus on core competencies, reduce costs, and address resource deficit challenges, especially in small to mid-sized companies. Applications range from managing clinical trial data to marketing, drug safety, and medical education, ultimately supporting the launch and lifecycle management of products. The end-use scope is extensive, especially within pharmaceutical and biotech sectors, where innovation drives growth, alongside an increase in complex therapy areas that demand specialized knowledge.

KEY MARKET STATISTICS
Base Year [2023] USD 9.78 billion
Estimated Year [2024] USD 11.16 billion
Forecast Year [2030] USD 25.39 billion
CAGR (%) 14.59%

Key factors influencing growth include rising R&D expenditures, increased emphasis on specialty drugs, and heightened demand for compliance and regulatory affairs management. The latest opportunities are underpinned by technological advancements like AI and machine learning that improve data management, analytics, and decision-making processes. Companies can capitalize on these by investing in technology-driven solutions and fostering partnerships with innovative outsourcing service providers. However, challenges such as data privacy concerns, quality control issues, and maintaining cohesive communication channels between third parties and in-house teams pose significant barriers. The regulatory landscape is also continually evolving, adding complexity to maintaining compliance.

Innovation opportunities lie in the use of digital health tools and personalized medicine approaches that demand rigorous medical affairs input. Research areas focusing on the integration of AI for real-time data analysis and predictive insights offer long-term value. As the market is characterized by rapid technological adoption and substantial competition, companies must aim for agility and strategic investments in scalable solutions. Successful navigation will rely on maintaining a clear focus on compliance, leveraging strategic collaborations, and enhancing service offerings to address evolving client needs efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of pharmaceutical pipeline and growing complexity of clinical data
    • Increase in the volume of medical publications and educational content
    • Rising demand for evidence-based medicine and value-based healthcare
  • Market Restraints
    • Limitations associated with communication and quality of outsourced functions
  • Market Opportunities
    • Inclusion of AI & ML technologies in medical affairs outsourcing
    • Strategic collaborations between pharmaceutical companies and outsourcing firms
  • Market Challenges
    • Concerns associated with confidentiality and data security risks

Porter's Five Forces: A Strategic Tool for Navigating the Medical Affairs Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Affairs Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Affairs Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Affairs Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Affairs Outsourcing Market

A detailed market share analysis in the Medical Affairs Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Affairs Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Affairs Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Affairs Outsourcing Market

A strategic analysis of the Medical Affairs Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Medical Communications, Medical Information Services, Medical Monitoring, Medical Science Liaisons, and Medical Writing & Publishing.
  • Based on Operational Model, market is studied across Full-Service Outsourcing, Functional Outsourcing, and Partial/Task-based Outsourcing.
  • Based on End-User, market is studied across Biotechnology & Pharmaceutical Companies, Contract Research Organization, Hospitals, Medical Device Companies, and Nursing Homes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of pharmaceutical pipeline and growing complexity of clinical data
      • 5.1.1.2. Increase in the volume of medical publications and educational content
      • 5.1.1.3. Rising demand for evidence-based medicine and value-based healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations associated with communication and quality of outsourced functions
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclusion of AI & ML technologies in medical affairs outsourcing
      • 5.1.3.2. Strategic collaborations between pharmaceutical companies and outsourcing firms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with confidentiality and data security risks
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways
    • 5.2.2. Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis
    • 5.2.3. End User: Diverse applications across end-users for operational cost efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Affairs Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Medical Communications
  • 6.3. Medical Information Services
  • 6.4. Medical Monitoring
  • 6.5. Medical Science Liaisons
  • 6.6. Medical Writing & Publishing

7. Medical Affairs Outsourcing Market, by Operational Model

  • 7.1. Introduction
  • 7.2. Full-Service Outsourcing
  • 7.3. Functional Outsourcing
  • 7.4. Partial/Task-based Outsourcing

8. Medical Affairs Outsourcing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology & Pharmaceutical Companies
  • 8.3. Contract Research Organization
  • 8.4. Hospitals
  • 8.5. Medical Device Companies
  • 8.6. Nursing Homes

9. Americas Medical Affairs Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Affairs Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Affairs Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
    • 12.3.2. Millstone Medical Outsourcing Completes Clean Room Facility Expansion
    • 12.3.3. ONO and Bristol Myers Squibb Sign Outsourcing Agreement with PRiME-R on Clinical Research of Opdivo in Patients with Gastric Cancer, utilizing CyberOncology in Japan
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accenture PLC
  • 2. Ashfield Healthcare Communications by Inizio
  • 3. Biomapas Group
  • 4. Charles River Laboratories International, Inc.
  • 5. Comprehend Systems, Inc. by Saama Technologies, Inc.
  • 6. Excelya
  • 7. Freyr Solutions
  • 8. Genpact
  • 9. Groupe ProductLife S.A.
  • 10. ICON PLC
  • 11. Indegene, Inc.
  • 12. Insuvia
  • 13. IQVIA Holdings, Inc.
  • 14. JSS Medical Research Inc
  • 15. Medpace Holdings, Inc.
  • 16. MMS Holdings Inc.
  • 17. PAREXEL International Corporation
  • 18. Pharmalex by BlueReg
  • 19. PPD, Inc. by Thermo Fischer Scientific Inc.
  • 20. ProPharma Group
  • 21. SGS S.A.
  • 22. Syneos Health, Inc.
  • 23. The Medical Affairs Company
  • 24. Wuxi Clinical Development, Inc.
  • 25. Zeincro Group

LIST OF FIGURES

  • FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL AFFAIRS OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL SCIENCE LIAISONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARTIAL/TASK-BASED OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023